These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31689354)

  • 1. Minor Hematochezia Decreases Use of Venous Thromboembolism Prophylaxis in Patients with Inflammatory Bowel Disease.
    Faye AS; Hung KW; Cheng K; Blackett JW; Mckenney AS; Pont AR; Li J; Lawlor G; Lebwohl B; Freedberg DE
    Inflamm Bowel Dis; 2020 Aug; 26(9):1394-1400. PubMed ID: 31689354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
    Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
    J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
    Tinsley A; Naymagon S; Trindade AJ; Sachar DB; Sands BE; Ullman TA
    J Clin Gastroenterol; 2013 Jan; 47(1):e1-6. PubMed ID: 22476043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Electronic Alert System Is Associated With a Significant Increase in Pharmacologic Venous Thromboembolism Prophylaxis Rates Among Hospitalized Inflammatory Bowel Disease Patients.
    Mathers B; Williams E; Bedi G; Messaris E; Tinsley A
    J Healthc Qual; 2017; 39(5):307-314. PubMed ID: 27153049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Nguyen GC; Murthy SK; Bressler B; Lam MCW; Alali A; Toumi A; Reinglas J; Rampersad A; Weizman AV; Afif W;
    Inflamm Bowel Dis; 2017 May; 23(5):695-701. PubMed ID: 28426451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in inflammatory bowel disease.
    Cheng K; Faye AS
    World J Gastroenterol; 2020 Mar; 26(12):1231-1241. PubMed ID: 32256013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors.
    Scoville EA; Konijeti GG; Nguyen DD; Sauk J; Yajnik V; Ananthakrishnan AN
    Inflamm Bowel Dis; 2014 Apr; 20(4):631-6. PubMed ID: 24552828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
    Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T
    Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease.
    Sam JJ; Bernstein CN; Razik R; Thanabalan R; Nguyen GC
    Dig Dis Sci; 2013 Jan; 58(1):46-52. PubMed ID: 23053902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study.
    McCurdy JD; Kuenzig ME; Smith G; Spruin S; Murthy SK; Carrier M; Nguyen GC; Benchimol EI
    Inflamm Bowel Dis; 2020 Oct; 26(11):1761-1768. PubMed ID: 31995204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in patients with inflammatory bowel disease: review of literature and practical algorithms.
    Coremans L; Strubbe B; Peeters H
    Acta Gastroenterol Belg; 2021; 84(1):79-85. PubMed ID: 33639697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk?
    Bryant RV; Jairath V; Curry N; Travis SP
    J Crohns Colitis; 2014 Feb; 8(2):166-71. PubMed ID: 24095288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization setting.
    Murthy SK; Robertson McCurdy AB; Carrier M; McCurdy JD
    Thromb Res; 2020 Oct; 194():26-32. PubMed ID: 32563061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Scoville E; Konijeti GG; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1905-10. PubMed ID: 24632349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology.
    Nguyen GC; Bernstein CN; Bitton A; Chan AK; Griffiths AM; Leontiadis GI; Geerts W; Bressler B; Butzner JD; Carrier M; Chande N; Marshall JK; Williams C; Kearon C
    Gastroenterology; 2014 Mar; 146(3):835-848.e6. PubMed ID: 24462530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital performance for pharmacologic venous thromboembolism prophylaxis and rate of venous thromboembolism : a cohort study.
    Flanders SA; Greene MT; Grant P; Kaatz S; Paje D; Lee B; Barron J; Chopra V; Share D; Bernstein SJ
    JAMA Intern Med; 2014 Oct; 174(10):1577-84. PubMed ID: 25133488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease Patients Hospitalized With a Central Line.
    Hamant LG; Gonzalez-Llanos L; Patel AS; McMahon L; Knoll C; Swing T; Pasternak B
    J Pediatr Gastroenterol Nutr; 2023 May; 76(5):610-615. PubMed ID: 36821846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.